Victory Capital Management
XGN icon

Victory Capital Management’s Exagen XGN Stock Holding History

Victory Capital Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,345
Closed -$545K – 2859
2021
Q2 		$545K Sell
36,345
-35,427
-49% -$543K ﹤0.01% 2163
2021
Q1 		$1.26M Sell
71,772
-1,330
-2% -$23.7K ﹤0.01% 1810
2020
Q4 		$965K Sell
73,102
-4,470
-6% -$63.1K ﹤0.01% 1799
2020
Q3 		$841K Sell
77,572
-3,440
-4% -$44.3K ﹤0.01% 1784
2020
Q2 		$1M Sell
81,012
-677,356
-89% -$9.17M ﹤0.01% 1734
2020
Q1 		$12.1M Buy
758,368
+370,294
+95% +$7.35M 0.01% 1022
2019
Q4 		$9.86M Sell
388,074
-36,926
-9% -$657K 0.01% 1018
2019
Q3 		$6.58M Buy
+425,000
New +$6.86M 0.01% 1104

Other funds holding XGN

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return

Victory Capital Management's XGN Position: Q3 2021 in Review

Victory Capital Management sold out of Exagen (XGN) in Q3 2021, closing a stake of 36,345 shares — an estimated $545K sold.

Victory Capital Management first reported a position in XGN in Q3 2019 and held it in 8 quarters. The position peaked at $12.1M in Q1 2020. 53 funds tracked by Wall St. Rank hold XGN as of Q3 2021.

  • Victory Capital Management reported no remaining Exagen position as of Q3 2021 after selling out during the quarter.
  • Victory Capital Management sold 36,345 Exagen shares in Q3 2021, an estimated $545K.
  • Victory Capital Management first reported a position in Exagen in Q3 2019 and held it in 8 quarters.
  • Victory Capital Management's Exagen position peaked at $12.1M in Q1 2020.
  • 53 funds tracked by Wall St. Rank held Exagen as of Q3 2021.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.